Bruns CJ - Search Results

1

Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis.

Seeliger H, Guba M, Kleespies A, Jauch KW, Bruns CJ. Seeliger H, et al. Among authors: bruns cj. Cancer Metastasis Rev. 2007 Dec;26(3-4):611-21. doi: 10.1007/s10555-007-9077-8. Cancer Metastasis Rev. 2007. PMID: 17713840 Review.

2

Vascular endothelial growth factor in colorectal cancer.

Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Guba M, et al. Int J Colorectal Dis. 2004 Nov;19(6):510-7. doi: 10.1007/s00384-003-0576-y. Epub 2004 Mar 4. Int J Colorectal Dis. 2004. PMID: 14999511 Review.

3

Cancer stem cells and angiogenesis.

Zhao Y, Bao Q, Renner A, Camaj P, Eichhorn M, Ischenko I, Angele M, Kleespies A, Jauch KW, Bruns C. Zhao Y, et al. Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz. Int J Dev Biol. 2011. PMID: 21732274 Free article. Review.

4

Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.

Seeliger H, Guba M, Koehl GE, Doenecke A, Steinbauer M, Bruns CJ, Wagner C, Frank E, Jauch KW, Geissler EK. Seeliger H, et al. Among authors: bruns cj. Clin Cancer Res. 2004 Mar 1;10(5):1843-52. doi: 10.1158/1078-0432.ccr-1176-3. Clin Cancer Res. 2004. PMID: 15014039

5

Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy.

Hartmann B, Schmid G, Graeb C, Bruns CJ, Fischereder M, Jauch KW, Heeschen C, Guba M. Hartmann B, et al. Among authors: bruns cj. Kidney Int. 2005 Dec;68(6):2593-8. doi: 10.1111/j.1523-1755.2005.00731.x. Kidney Int. 2005. PMID: 16316335 Free article. Clinical Trial.

6

Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model.

Conrad C, Ischenko I, Köhl G, Wiegand U, Guba M, Yezhelyev M, Ryan AJ, Barge A, Geissler EK, Wedge SR, Jauch KW, Bruns CJ. Conrad C, et al. Among authors: bruns cj. Anticancer Drugs. 2007 Jun;18(5):569-79. doi: 10.1097/CAD.0b013e3280147d13. Anticancer Drugs. 2007. PMID: 17414626

7

Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.

Ischenko I, Guba M, Yezhelyev M, Papyan A, Schmid G, Green T, Fennell M, Jauch KW, Bruns CJ. Ischenko I, et al. Among authors: bruns cj. Angiogenesis. 2007;10(3):167-82. doi: 10.1007/s10456-007-9071-3. Epub 2007 May 8. Angiogenesis. 2007. PMID: 17486419

8

Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer.

Manegold PC, Paringer C, Kulka U, Krimmel K, Eichhorn ME, Wilkowski R, Jauch KW, Guba M, Bruns CJ. Manegold PC, et al. Among authors: bruns cj. Clin Cancer Res. 2008 Feb 1;14(3):892-900. doi: 10.1158/1078-0432.CCR-07-0955. Clin Cancer Res. 2008. PMID: 18245553

9

[Tumor and transplantation].

Guba M, Andrassy J, Angele M, Bruns C. Guba M, et al. Chirurg. 2013 Aug;84(8):690-7. doi: 10.1007/s00104-012-2426-3. Chirurg. 2013. PMID: 23831889 Review. German.

10

FTY720 inhibits tumor growth and angiogenesis.

Schmid G, Guba M, Papyan A, Ischenko I, Brückel M, Bruns CJ, Jauch KW, Graeb C. Schmid G, et al. Among authors: bruns cj. Transplant Proc. 2005 Jan-Feb;37(1):110-1. doi: 10.1016/j.transproceed.2004.12.278. Transplant Proc. 2005. PMID: 15808563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

628 results

Search Page